We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$11.3B
AUM Growth
+$944M
Cap. Flow
+$192M
Cap. Flow %
1.71%
Top 10 Hldgs %
20.34%
Holding
124
New
4
Increased
77
Reduced
34
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 24.06%
2 Technology 18.31%
3 Industrials 15.46%
4 Financials 13.16%
5 Consumer Staples 11.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRSK icon
26
Verisk Analytics
VRSK
$27.9B
$136M 1.21%
1,130,080
+44,020
+4% +$5.12M
FLO icon
27
Flowers Foods
FLO
$1.58B
$134M 1.19%
7,204,665
+452,045
+7% +$9.13M
SBH icon
28
Sally Beauty Holdings
SBH
$1.47B
$132M 1.17%
7,194,560
+3,018,900
+72% +$48.3M
SXT icon
29
Sensient Technologies
SXT
$5.22B
$129M 1.15%
1,691,675
+524,280
+45% +$37.4M
ULTA icon
30
Ulta Beauty
ULTA
$21.8B
$126M 1.12%
445,910
-4,465
-1% -$1.14M
ROK icon
31
Rockwell Automation
ROK
$51.1B
$126M 1.11%
670,005
+74,360
+12% +$13.3M
WBT
32
DELISTED
Welbilt, Inc.
WBT
$125M 1.1%
5,966,285
+277,115
+5% +$6.1M
LH icon
33
Labcorp
LH
$25.2B
$122M 1.09%
820,358
-95,274
-10% -$14.5M
COO icon
34
Cooper Companies
COO
$14.2B
$122M 1.08%
1,762,700
+58,740
+3% +$3.77M
TECH icon
35
Bio-Techne
TECH
$11.2B
$121M 1.08%
2,376,540
+308,360
+15% +$13.7M
AME icon
36
Ametek
AME
$53.9B
$119M 1.06%
1,507,885
+55,710
+4% +$4.27M
MKC icon
37
McCormick & Company Non-Voting
MKC
$14B
$119M 1.05%
1,803,290
+48,250
+3% +$2.98M
JBTM
38
JBT Marel
JBTM
$7.35B
$117M 1.04%
982,800
+50,185
+5% +$5.46M
IFF icon
39
International Flavors & Fragrances
IFF
$20.3B
$115M 1.02%
827,495
+74,840
+10% +$9.84M
EW icon
40
Edwards Lifesciences
EW
$49.4B
$115M 1.02%
1,976,895
+65,925
+3% +$3.22M
CNMD icon
41
CONMED
CNMD
$1.3B
$109M 0.97%
1,375,655
+40,100
+3% +$3.1M
HELE icon
42
Helen of Troy
HELE
$656M
$109M 0.96%
831,035
-1,465
-0.2% -$173K
AAP icon
43
Advance Auto Parts
AAP
$3.53B
$108M 0.96%
644,385
-135,545
-17% -$20.8M
AVNS icon
44
Avanos Medical
AVNS
$107M 0.95%
1,565,996
+525,206
+50% +$33.8M
FTV icon
45
Fortive
FTV
$18.2B
$106M 0.94%
2,004,669
+716,354
+56% +$36.7M
ARGO
46
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$106M 0.94%
1,674,693
+153,811
+10% +$9.47M
GTES icon
47
Gates Industrial Corporation Ltd.
GTES
$6.31B
$104M 0.92%
5,335,315
+467,110
+10% +$8.17M
TAP icon
48
Molson Coors Class B
TAP
$8.02B
$104M 0.92%
1,685,795
+75,870
+5% +$5.02M
DATA
49
DELISTED
Tableau Software, Inc.
DATA
$101M 0.9%
904,655
+38,840
+4% +$4.19M
NEWR
50
DELISTED
New Relic, Inc.
NEWR
$99.3M 0.88%
1,053,590
-3,790
-0.4% -$393K

Similar funds

Champlain Investment Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Champlain Investment Partners held 124 positions worth $11.3B, up 9.1% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Champlain Investment Partners's Q3 2018 filing shows 4 new, 77 increased, 34 reduced and 6 closed positions. Its largest new stake was Altra Industrial Motion Corp: 1,272,680 shares worth $52.6M. The largest sale was Financial Engines, Inc., an estimated $119M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Champlain Investment Partners's largest Q3 2018 buy was Altra Industrial Motion Corp: 1,272,680 shares worth $52.6M.
  • Champlain Investment Partners added most to Sally Beauty Holdings in Q3 2018, an estimated $48.3M increase.
  • Champlain Investment Partners's biggest Q3 2018 reduction was Guidewire Software, cutting an estimated $62.4M.
  • Champlain Investment Partners fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $119M.
  • Champlain Investment Partners's ten largest holdings make up 20% of its $11.3B portfolio in Q3 2018.
  • Champlain Investment Partners opened 4 new positions and closed 6 in Q3 2018.
  • Champlain Investment Partners's portfolio value rose 9.1% quarter-over-quarter to $11.3B.

Based on Champlain Investment Partners's 13F filing for Q3 2018, filed 13 Nov 2018.